Liquidia (LQDA) Other Operating Expenses (2020 - 2026)
Liquidia's (LQDA) quarterly Other Operating Expenses came in at $11.9 million in Q1 2026, up 681.28% year-on-year from $1.5 million in Q1 2025, and up 67.99% quarter-over-quarter from $7.1 million in Q4 2025.
Liquidia (LQDA) Other Operating Expenses (2020 - 2026) Analysis & Trends
Liquidia's Other Operating Expenses history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 681.28% year-over-year to $11.9 million in Q1 2026; TTM through Mar 2026 was $23.6 million, a 297.66% increase from a year earlier, with the FY2025 full-year figure at $13.2 million, up 125.24% from the prior year.
- Other Operating Expenses climbed to $11.9 million in Q1 2026 per LQDA's latest filing, from $7.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $11.9 million in Q1 2026 and bottomed at $570000.0 in Q3 2023.
- The 5-year median for Other Operating Expenses is $1.4 million (2024), against an average of $2.2 million.
- Across the five-year window, Other Operating Expenses retreated 22.97% in 2023 and jumped 681.28% in 2026, its largest moves.
- Year by year, Other Operating Expenses stood at $694000.0 in 2022, then soared by 43.08% to $993000.0 in 2023, then jumped by 36.35% to $1.4 million in 2024, then jumped by 421.05% to $7.1 million in 2025, then jumped by 67.99% to $11.9 million in 2026.
- Per Business Quant, the three latest LQDA Other Operating Expenses figures stand at $11.9 million (Q1 2026), $7.1 million (Q4 2025), and $3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.85 Mn |
| Dec 31, 2025 | 7.06 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 993,000.00 |
| Sep 30, 2023 | 570,000.00 |
| Jun 30, 2023 | 671,000.00 |
| Mar 31, 2023 | 654,000.00 |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 740,000.00 |
| Jun 30, 2022 | 731,000.00 |
| Mar 31, 2022 | 694,000.00 |
| Dec 31, 2021 | 726,000.00 |
| Sep 30, 2021 | 890,000.00 |
| Jun 30, 2021 | 714,000.00 |